leisure time -WSS

leisure time

author：Wikipedia 2025-09-28 00:52:52 - browse：7841

3D DNA on a sheet of paper listing nucleic acid sequences — coverage from STAT — Adobe

Ultima Genomics, an upstart some observers have called a “dark horse” in the world of DNA sequencing, will soon launch a line of high-power instruments that can read a human genome for as little as $100, the company’s leadership told STAT.

The sequencer, dubbed the UG 100, is a $1.5 million machine that can read up to 20,000 human genomes a year. The reagents required to operate the instrument cost as little as $1 per billion sequenced DNA bases; that translates to $100 per genome assuming each base in the 3-gigabase human genome is read 33 times, a common industry standard. The company plans to officially launch the product at this year’s Advances in Genome Biology and Technology meeting, which kicks off in Orlando, Fla., on Feb. 5.

The product’s cost and maximum output put it roughly in the same range as a line of high-throughput instruments launched in September 2022 by Illumina, which controls an estimated 80% of the sequencing market. But Ultima is hoping it can chip into the sequencing giant’s market share among genome centers, large clinical labs, and others with an appetite for reams of genetic data by offering lower operating costs and greater flexibility.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： ChatGPT in medicine: STAT answers readers' burning questions
Next article： Publishing genetic code of viruses could cause disaster

leisure time

WSS

Headspace, Meta partner to launch VR meditation app for Quest

Readout Newsletter: Ozempic panic wanes, Legend x Novartis, etc.

RSV shot was 90% effective at preventing hospitalizations in kids

FDA cancer chief on how to get things done: ‘Don’t tell anybody'

White House drug czar issues call for 'recovery

Novo Nordisk obesity pill bests Wegovy in early trial

knowledge

leisure time

hotspot

After affirmative action ruling, medical educators look to 'holistic review'

What is STAT's opinion section for?

Medical leaders decry Supreme Court decision on affirmative action

Change Healthcare cyberattack prompts Medicare loan program

Medicare details structure of new drug price negotiation program

Readout Newsletter: Zepbound, Valneva's vaccine, and more

FDA approval of Sarepta Duchenne genetic therapy gives me hope

Change Healthcare payments predicted restored March 15

Medical records are filled with copy

What is STAT's opinion section for?

hotspot

Readout LOUD Podcast: Lilly's obesity drug, the power of radiation

FDA reorg will put new emphasis on investigations, sources say

The drug industry has found itself all alone in Washington

Headspace, Meta partner to launch VR meditation app for Quest

Novo Nordisk gets FDA approval to tout heart benefits of Wegovy

What health policies could hitch a ride on a spending bill?

leisure time

knowledge

focus

leisure time